David Shugar

14.1k total citations · 2 hit papers
436 papers, 11.6k citations indexed

About

David Shugar is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, David Shugar has authored 436 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 292 papers in Molecular Biology, 129 papers in Organic Chemistry and 73 papers in Infectious Diseases. Recurrent topics in David Shugar's work include Biochemical and Molecular Research (128 papers), DNA and Nucleic Acid Chemistry (100 papers) and HIV/AIDS drug development and treatment (72 papers). David Shugar is often cited by papers focused on Biochemical and Molecular Research (128 papers), DNA and Nucleic Acid Chemistry (100 papers) and HIV/AIDS drug development and treatment (72 papers). David Shugar collaborates with scholars based in Poland, Slovakia and Belgium. David Shugar's co-authors include Agnieszka Bzowska, Jack J. Fox, Ewa Kulikowska, Erik De Clercq, Jan Antosiewicz, Borys Kierdaszuk, Halina Sierakowska, Zygmunt Kazimierczuk, Ryszard Stolarski and Paul F. Torrence and has published in prestigious journals such as Nature, Science and Journal of the American Chemical Society.

In The Last Decade

David Shugar

431 papers receiving 10.7k citations

Hit Papers

The measurement of lysozyme activity and the ultra-violet... 1952 2026 1976 2001 1952 1980 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Shugar Poland 48 7.7k 2.4k 1.5k 1.4k 1.1k 436 11.6k
Roland K. Robins United States 57 7.6k 1.0× 6.9k 2.9× 2.2k 1.4× 2.8k 2.0× 489 0.5× 466 14.3k
Robert Bittman United States 67 11.3k 1.5× 2.7k 1.1× 1.1k 0.7× 916 0.7× 677 0.6× 380 16.0k
Vern L. Schramm United States 63 9.9k 1.3× 2.0k 0.8× 2.6k 1.7× 2.2k 1.6× 1.6k 1.5× 354 14.0k
Richard Wolfenden United States 55 9.4k 1.2× 2.2k 0.9× 409 0.3× 504 0.4× 2.6k 2.4× 189 12.5k
G. Michael Blackburn United Kingdom 45 4.3k 0.6× 2.3k 0.9× 785 0.5× 353 0.3× 776 0.7× 242 7.7k
Richard M. Epand Canada 78 19.2k 2.5× 2.8k 1.2× 1.5k 1.0× 810 0.6× 776 0.7× 541 25.4k
Peter Reichard Sweden 74 12.4k 1.6× 782 0.3× 967 0.6× 1.0k 0.7× 1.8k 1.6× 231 16.9k
Shinichi Kondo Japan 56 6.5k 0.8× 2.8k 1.2× 1.7k 1.1× 347 0.3× 1.7k 1.6× 548 13.9k
L. Mario Amzel United States 70 9.7k 1.3× 1.5k 0.6× 503 0.3× 521 0.4× 1.7k 1.5× 246 14.7k
Alan C. Sartorelli United States 59 8.5k 1.1× 3.1k 1.3× 807 0.5× 726 0.5× 504 0.5× 514 15.9k

Countries citing papers authored by David Shugar

Since Specialization
Citations

This map shows the geographic impact of David Shugar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Shugar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Shugar more than expected).

Fields of papers citing papers by David Shugar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Shugar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Shugar. The network helps show where David Shugar may publish in the future.

Co-authorship network of co-authors of David Shugar

This figure shows the co-authorship network connecting the top 25 collaborators of David Shugar. A scholar is included among the top collaborators of David Shugar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Shugar. David Shugar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wierzchowski, Jacek, Jan Antosiewicz, & David Shugar. (2014). 8-Azapurines as isosteric purine fluorescent probes for nucleic acid and enzymatic research. Molecular BioSystems. 10(11). 2756–2774. 41 indexed citations
2.
Poznański, Jarosław, Anna Poznańska, & David Shugar. (2014). A Protein Data Bank Survey Reveals Shortening of Intermolecular Hydrogen Bonds in Ligand-Protein Complexes When a Halogenated Ligand Is an H-Bond Donor. PLoS ONE. 9(6). e99984–e99984. 16 indexed citations
3.
Wielechowska, Monika, et al.. (2014). Thermodynamic parameters for binding of some halogenated inhibitors of human protein kinase CK2. Biochemical and Biophysical Research Communications. 456(1). 282–287. 16 indexed citations
4.
Antosiewicz, Jan & David Shugar. (2011). Poisson–Boltzmann continuum-solvation models: applications to pH-dependent properties of biomolecules. Molecular BioSystems. 7(11). 2923–2949. 18 indexed citations
5.
Bretner, Maria, et al.. (2003). Selectivity of 4,5,6,7-tetrabromobenzimidazole [TBBZ] as an ATP-competitive potent inhibitor of protein kinase CK2 from various sources. Cellular & Molecular Biology Letters. 8. 6 indexed citations
6.
Wielgus‐Kutrowska, Beata, Agnieszka Bzowska, Jan Tebbe, Gertraud Koellner, & David Shugar. (2002). Purine nucleoside phosphorylase from Cellulomonas sp.: physicochemical properties and binding of substrates determined by ligand-dependent enhancement of enzyme intrinsic fluorescence, and by protective effects of ligands on thermal inactivation of the enzyme. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1597(2). 320–334. 19 indexed citations
7.
Bzowska, Agnieszka, Ewa Kulikowska, & David Shugar. (2000). Purine nucleoside phosphorylases: properties, functions, and clinical aspects. Pharmacology & Therapeutics. 88(3). 349–425. 403 indexed citations
8.
Tebbe, Jan, Agnieszka Bzowska, Beata Wielgus‐Kutrowska, et al.. (1999). Crystal structure of the purine nucleoside phosphorylase (PNP) from Cellulomonas sp. and its implication for the mechanism of trimeric PNPs. Journal of Molecular Biology. 294(5). 1239–1255. 56 indexed citations
9.
Kierdaszuk, Borys, Krzysztof Krawiec, Zygmunt Kazimierczuk, et al.. (1998). Substrate/Inhibitor Specificities of Human Deoxycytidine Kinase (DCK) and Thymidine Kinases (TK1 and TK2). Advances in experimental medicine and biology. 431. 623–627. 5 indexed citations
10.
Koellner, Gertraud, Marija Luić, David Shugar, Wolfram Saenger, & Agnieszka Bzowska. (1997). Crystal structure of calf spleen purine nucleoside phosphorylase in a complex with hypoxanthine at 2.15 Å resolution. Journal of Molecular Biology. 265(2). 202–216. 74 indexed citations
11.
Weekes, John, Simon A. Hawley, Julia M. Corton, David Shugar, & D. Grahame Hardie. (1994). Activation of rat liver AMP‐activated protein kinase by kinase kinase in a purified, reconstituted system. European Journal of Biochemistry. 219(3). 751–757. 67 indexed citations
12.
Bzowska, Agnieszka, et al.. (1991). Acyclonucleoside analogue inhibitors of mammalian purine nucleoside phosphorylase. Biochemical Pharmacology. 41(12). 1791–1803. 29 indexed citations
13.
Stolarski, Ryszard, et al.. (1984). Studies on the dynamic syn‐anti equilibrium in purine nucleosides and nucleotides with the aid of 1H and 13C NMR spectroscopy. European Journal of Biochemistry. 138(1). 187–192. 37 indexed citations
14.
Shugar, David, et al.. (1983). Obituary: Professor Michael Laskowski Sr.. PubMed. 30(2). 113–4. 1 indexed citations
15.
Sierakowska, Halina & David Shugar. (1977). Mammalian Nucleolytic Enzymes. Progress in nucleic acid research and molecular biology. 20. 59–130. 105 indexed citations
16.
Fikus, M, et al.. (1974). Biochemical studies on some new analogues of adenosine-3'5'-cyclic phosphate, including isoguanosine-3 ,5-cylic phosphate.. PubMed. 21(4). 465–74. 3 indexed citations
17.
Shugar, David, et al.. (1972). Radio-products of Thymine in the Presence of Ethanol. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine. 21(2). 101–114. 6 indexed citations
18.
Shugar, David. (1969). Biochemical aspects of antimetabolites and of drug hydroxylation. Academic Press eBooks. 37 indexed citations
19.
Szer, W., et al.. (1965). Some properties of poly-ribothymidylic acid, co-polymers of uridylic and ribothymidylic acids, and their 1:1 complexes with polyadenylic acid.. PubMed. 342(4). 429–36. 1 indexed citations
20.
Janion, Celina & David Shugar. (1965). Reaction of hydroxylamine with 5-substituted cytosines. Biochemical and Biophysical Research Communications. 18(4). 617–622. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026